Showing results (141-150 of 395) with videos related to
Sort By:
Pageof 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemiaAlexander Kröber, Johannes Bloehdorn, Sebastian Hafner, et al.Oncotarget|October 23, 2018
Functional characterization of phospholipase C-γ2 mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorderClaudia Walliser, Martin Wist, Elisabeth Hermkes, et al.International Journal of Cancer|October 12, 2005
Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancerStephan Wolf, Daniel Mertens, Armin Pscherer, et al.The Journal of Biological Chemistry|March 19, 2020
Noncatalytic Bruton's tyrosine kinase activates PLCγ2 variants mediating ibrutinib resistance in human chronic lymphocytic leukemia cellsMartin Wist, Laura Meier, Orit Gutman, et al.Haematologica|December 3, 2009
Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemiaDirk Kienle, Axel Benner, Carolin Läufle, et al.Blood|December 1, 2010
DNA damage-induced transcriptional program in CLL: biological and diagnostic implications for functional p53 testingJulia Mohr, Hanne Helfrich, Maxi Fuge, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
TP53 mutation and survival in chronic lymphocytic leukemiaThorsten Zenz, Barbara Eichhorst, Raymonde Busch, et al.Plos One|February 6, 2013
Germline allele-specific expression of DAPK1 in chronic lymphocytic leukemiaQuan-Xiang Wei, Rainer Claus, Thomas Hielscher, et al.Cancers|April 23, 2022
Deep Neural Networks and Machine Learning Radiomics Modelling for Prediction of Relapse in Mantle Cell LymphomaCatharina Silvia Lisson, Christoph Gerhard Lisson, Marc Fabian Mezger, et al.Blood|October 23, 2008
miR-34a as part of the resistance network in chronic lymphocytic leukemiaThorsten Zenz, Julia Mohr, Eric Eldering, et al.Pageof 40